Please login to the form below
ezetimibe
This page shows the latest ezetimibe news and features for those working in and with pharma, biotech and healthcare.
UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients
Uncertainties remain around the clinical data for Leqvio, with NICE pointing to the lack of data directly comparing it to other treatments, Organon’s cholesterol absorption blocker Ezetrol (ezetimibe) and Regeneron
Latest news
-
Merck spin-off Organon sees share price jump at Q2 results
cholesterol drug Zetia (ezetimibe) in Japan.
-
Esperion gets FDA thumbs up for cholesterol drug Nexletol
market since Merck &Co got approval for Zetia (ezetimibe) in 2002. ... The company has also filed bempedoic acid in Europe, as well as a combination pill with ezetimibe, filed with both the FDA and EMA.
-
Novartis links up with NHS for speedy access to cholesterol drug inclisiran
with or without Merck &Co’s add-on therapy Zetia (ezetimibe).
-
TMC rockets on data for twice-yearly cholesterol drug inclisiran
control the LDL-cholesterol levels despite maximum doses of statin drugs, with or without Merck &Co’s add-on therapy Zetia (ezetimibe).
-
Esperion craters as deaths mar atherosclerosis drug study
earlier phase III trial and the company has reiterated its plans to file for approval as a monotherapy and in combination with Merck &Co/MSD’s Zetia (ezetimibe) in the US
More from news
Approximately 4 fully matching, plus 43 partially matching documents found.
Latest Intelligence
-
Reaching patients and HCPs during the pandemic
Esperion planned to launch its lipid-lowering agent, Nexletol (bempedoic acid), in March 2020 before releasing the combination therapy, Nexlizet (bempedoic acid/ezetimibe), in July.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
